Clinical Trials in Cairns, Australia

5 recruiting

Showing 120 of 25 trials

Recruiting
Phase 2Phase 3

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Non-small Cell Lung Cancer
BioNTech SE1,260 enrolled206 locationsNCT06712316
Recruiting
Phase 3

Duration of Anti-PD-1 Therapy in Metastatic Melanoma

Unresectable/Metastatic Melanoma
Canadian Cancer Trials Group614 enrolled30 locationsNCT02821013
Recruiting
Phase 3

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
Phase 2Phase 3

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

Atherosclerotic Cardiovascular Disease
CSL Behring2,310 enrolled538 locationsNCT05485961
Recruiting

The Australian HCV Point-of-Care Testing Program

Hepatitis C
Kirby Institute60,000 enrolled69 locationsNCT05042544
Recruiting
Phase 3

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Intellia Therapeutics1,200 enrolled132 locationsNCT06128629
Recruiting
Phase 3

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Heart Failure and Impaired Kidney Function
AstraZeneca4,800 enrolled842 locationsNCT06307652
Recruiting
Phase 2

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca1,160 enrolled363 locationsNCT07082738
Recruiting
Phase 3

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Extensive-stage Small-cell Lung Cancer
BioNTech SE621 enrolled138 locationsNCT06712355
Recruiting
Phase 3

Fibrinogen Early In Severe Trauma StudY II

TraumaHaemorrhagic Shock
Australian and New Zealand Intensive Care Research Centre900 enrolled24 locationsNCT05449834
Recruiting

IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma

Melanoma (Skin Cancer)
Peter MacCallum Cancer Centre, Australia80 enrolled6 locationsNCT07138222
Recruiting

Resorbable Magnesium Scaffolds Registry

Coronary Artery Disease
Biotronik AG1,106 enrolled13 locationsNCT04679740
Recruiting
Phase 4

Staphylococcus Aureus Network Adaptive Platform Trial

Staphylococcus Aureus Bacteremia
University of Melbourne8,000 enrolled151 locationsNCT05137119
Recruiting

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

Alexion Pharmaceuticals, Inc.3,000 enrolled141 locationsNCT01522183
Recruiting
Not Applicable

Guideline Oriented Approach To Lipid Lowering In Asia-Pacific

Cardiovascular DiseasesAcute Coronary SyndromeAtherosclerosis+1 more
Stephen Nicholls2,000 enrolled22 locationsNCT05325034
Recruiting
Phase 3

Better Evidence and Translation for Calciphylaxis

Calciphylaxis
University of Sydney350 enrolled21 locationsNCT05018221
Recruiting
Phase 3

ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients

Traumatic Brain InjuryWounds and InjuriesTrauma+3 more
Australian and New Zealand Intensive Care Research Centre2,500 enrolled41 locationsNCT04588311
Recruiting
Not Applicable

Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

Kidney Failure, ChronicHyperphosphatemia
The University of Queensland3,600 enrolled115 locationsNCT03573089
Recruiting

Real World Assessment of People Living With Chronic Hepatitis B in Australia

Hepatitis B
Kirby Institute10,000 enrolled19 locationsNCT04914611
Recruiting
Phase 2

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Solid Tumor, Adult
Omico96 enrolled13 locationsNCT06003621